<?xml version="1.0" ?>
<document id="b950247dbac25ce91de13806e102102a757c16ca">
  <chunk id="b950247dbac25ce91de13806e102102a757c16ca.c0" text="Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity OPEN"/>
  <chunk id="b950247dbac25ce91de13806e102102a757c16ca.c1" text="of the virus per se and cellular NF-κB activity; and (ii) to study the underling mechanisms. We found that tylophorine-based compounds target the TGEV viral RNA and effectively inhibit TGEV replication. NF-κB inhibition also leads to anti-TGEV replication. NF-κB activation induced by TGEV infection was found to be associated with two convergent pathways, IKK-2_IκBα/p65 and JAK2 mediated p65 phosphorylation, in swine testicular cells. JAK2 inhibition either by CYT387 (a JAK family inhibitor) or by silencing JAK2-expression revealed a dominant JAK2 mediated p65 phosphorylation pathway for NF-κB activation and resulted in NF-κB inhibition, which overrode the IκBα regulation via the IKK-2. Finally, tylophorine-based compounds work cooperatively with CYT387 to impart comprehensive anti-TGEV activities. The combination treatment, wherein a tylophorine compound targets TGEV and a JAK2 inhibitor blocks the alternative dominant NF-κB activation mediated by JAK2, is more effective and comprehensive than either one alone and constitutes a feasible approach for the treatment of SARS-CoV or MERS-CoV.">
    <entity charOffset="157-160" id="b950247dbac25ce91de13806e102102a757c16ca.c1.e0" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
    <entity charOffset="464-470" id="b950247dbac25ce91de13806e102102a757c16ca.c1.e1" ontology_id="CHEBI_91407" text="CYT387" type="chemical"/>
    <entity charOffset="485-494" id="b950247dbac25ce91de13806e102102a757c16ca.c1.e2" ontology_id="CHEBI_35222" text="inhibitor" type="chemical"/>
    <entity charOffset="582-589" id="b950247dbac25ce91de13806e102102a757c16ca.c1.e3" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="756-762" id="b950247dbac25ce91de13806e102102a757c16ca.c1.e4" ontology_id="CHEBI_91407" text="CYT387" type="chemical"/>
    <entity charOffset="846-857" id="b950247dbac25ce91de13806e102102a757c16ca.c1.e5" ontology_id="CHEBI_9786" text="tylophorine" type="chemical"/>
    <entity charOffset="886-900" id="b950247dbac25ce91de13806e102102a757c16ca.c1.e6" ontology_id="CHEBI_76617" text="JAK2 inhibitor" type="chemical"/>
    <entity charOffset="891-900" id="b950247dbac25ce91de13806e102102a757c16ca.c1.e7" ontology_id="CHEBI_35222" text="inhibitor" type="chemical"/>
  </chunk>
  <chunk id="b950247dbac25ce91de13806e102102a757c16ca.c2" text="Coronaviruses are animal viruses containing an enveloped, positive-sense, single-stranded RNA genome; and include the common cold human coronavirus (CoV)-229E &amp; CoV-OC43, severe acute respiratory syndrome (SARS) CoV, Middle East respiratory syndrome (MERS) CoV, porcine transmissible gastroenteritis virus (TGEV), and murine hepatitis virus (MHV) etc 1-3 . Since the 2003 SARS outbreak (which had a mortality rate of ~10%), novel anti-SARS-CoV treatments have been vigorously pursued. No new cases of SARS have been reported since the 2003 outbreak, but another novel coronavirus (MERS-CoV), this time with a mortality rate of ~35%, came to light in 2012 4 . To date, neither a commercially available vaccine for human coronaviruses nor a specific treatment for SARS-CoV or MERS-CoV is available.">
    <entity charOffset="90-93" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
    <entity charOffset="118-129" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e1" ontology_id="DOID_10459" text="common cold" type="disease"/>
    <entity charOffset="125-129" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e2" ontology_id="DOID_3083" text="cold" type="disease"/>
    <entity charOffset="171-204" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e3" ontology_id="DOID_2945" text="severe acute respiratory syndrome" type="disease"/>
    <entity charOffset="196-204" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e4" ontology_id="DOID_225" text="syndrome" type="disease"/>
    <entity charOffset="206-210" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e5" ontology_id="DOID_2945" text="SARS" type="disease"/>
    <entity charOffset="217-249" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e6" ontology_id="DOID_0080642" text="Middle East respiratory syndrome" type="disease"/>
    <entity charOffset="241-249" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e7" ontology_id="DOID_225" text="syndrome" type="disease"/>
    <entity charOffset="284-299" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e8" ontology_id="DOID_2326" text="gastroenteritis" type="disease"/>
    <entity charOffset="325-334" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e9" ontology_id="DOID_2237" text="hepatitis" type="disease"/>
    <entity charOffset="372-376" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e10" ontology_id="DOID_2945" text="SARS" type="disease"/>
    <entity charOffset="501-505" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e11" ontology_id="DOID_2945" text="SARS" type="disease"/>
    <entity charOffset="641-646" id="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" ontology_id="CHEBI_30212" text="light" type="chemical"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e1" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p0" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e2" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p1" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e3" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p2" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e4" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p3" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e5" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p4" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e6" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p5" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e7" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p6" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e8" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p7" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e9" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p8" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e10" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p9" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e11" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p10" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e1" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p11" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e2" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p12" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e3" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p13" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e4" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p14" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e5" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p15" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e6" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p16" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e7" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p17" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e8" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p18" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e9" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p19" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e10" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p20" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c2.e11" e2="b950247dbac25ce91de13806e102102a757c16ca.c2.e12" id="b950247dbac25ce91de13806e102102a757c16ca.c2.p21" relation="true"/>
  </chunk>
  <chunk id="b950247dbac25ce91de13806e102102a757c16ca.c3" text="Coronaviruses primarily infect the upper respiratory and gastrointestinal tract and induce host inflammation 5 . Nuclear factor κB (NF-κB) activation by coronaviruses is usually responsible for mediating the production of pro-inflammatory cytokines and chemokines and thus plays an important role in the pathogenesis of disease caused by coronaviruses 6, 7 . Inhibition of NF-κB-mediated inflammation induced by coronavirus in mice was reported to increase the survival rate 6 . Thus, NF-κB inhibitors constitute a promising class of antivirals in infections caused by pathogenic coronaviruses. However, targeting NF-κB is limited by intrinsic pathway complexity, cross talk with other pathways, and drug resistance 8 . In addition, many small chemical molecules targeting either viral entry or the intracellular viral life cycle were reported to impart anti-coronavirus activity 2, 9, 10 . Despite these advances, however, SARS-CoV and MERS-CoV remain untreatable diseases for which novel therapies are sought.">
    <entity charOffset="292-296" id="b950247dbac25ce91de13806e102102a757c16ca.c3.e0" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <entity charOffset="320-327" id="b950247dbac25ce91de13806e102102a757c16ca.c3.e1" ontology_id="DOID_4" text="disease" type="disease"/>
    <entity charOffset="491-501" id="b950247dbac25ce91de13806e102102a757c16ca.c3.e2" ontology_id="CHEBI_35222" text="inhibitors" type="chemical"/>
    <entity charOffset="534-544" id="b950247dbac25ce91de13806e102102a757c16ca.c3.e3" ontology_id="CHEBI_22587" text="antivirals" type="chemical"/>
    <entity charOffset="644-651" id="b950247dbac25ce91de13806e102102a757c16ca.c3.e4" ontology_id="CHEBI_34922" text="pathway" type="chemical"/>
    <entity charOffset="700-704" id="b950247dbac25ce91de13806e102102a757c16ca.c3.e5" ontology_id="CHEBI_23888" text="drug" type="chemical"/>
    <entity charOffset="753-762" id="b950247dbac25ce91de13806e102102a757c16ca.c3.e6" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c3.e0" e2="b950247dbac25ce91de13806e102102a757c16ca.c3.e1" id="b950247dbac25ce91de13806e102102a757c16ca.c3.p0" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c3.e1" e2="b950247dbac25ce91de13806e102102a757c16ca.c3.e2" id="b950247dbac25ce91de13806e102102a757c16ca.c3.p1" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c3.e1" e2="b950247dbac25ce91de13806e102102a757c16ca.c3.e3" id="b950247dbac25ce91de13806e102102a757c16ca.c3.p2" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c3.e1" e2="b950247dbac25ce91de13806e102102a757c16ca.c3.e4" id="b950247dbac25ce91de13806e102102a757c16ca.c3.p3" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c3.e1" e2="b950247dbac25ce91de13806e102102a757c16ca.c3.e5" id="b950247dbac25ce91de13806e102102a757c16ca.c3.p4" relation="true"/>
    <pair e1="b950247dbac25ce91de13806e102102a757c16ca.c3.e1" e2="b950247dbac25ce91de13806e102102a757c16ca.c3.e6" id="b950247dbac25ce91de13806e102102a757c16ca.c3.p5" relation="true"/>
  </chunk>
  <chunk id="b950247dbac25ce91de13806e102102a757c16ca.c4" text="Published: xx xx xxxx OPEN www.nature.com/scientificreports/ 2 Scientific RepoRts | 7: 4105 | Tylophorine based compounds, whether isolated from plants, e.g. Asclepiadaceae and Moraceae or chemically synthesized, exert potent anti-coronaviral activities against a variety of coronaviruses including SARS-CoV, MHV, and TGEV 11, 12 , but both the underlying mechanism(s) of this inhibitory effect and the target are unknown. NF-κB is significantly activated after infection by coronaviruses, e.g. TGEV, and MHV etc 6, 7, [13] [14] [15] . Otherwise, coronaviral nucleocapsid (N) protein plays a vital role in the regulation of viral genome replication and host gene transcription 16 . Therefore, the combination treatment for the inhibition of coronavirus per se, e.g. viral genome replication, and blocking cellular NF-κB activation by coronaviruses, is a promising approach for the development of anti-coronavirals.">
    <entity charOffset="94-105" id="b950247dbac25ce91de13806e102102a757c16ca.c4.e0" ontology_id="CHEBI_9786" text="Tylophorine" type="chemical"/>
    <entity charOffset="576-583" id="b950247dbac25ce91de13806e102102a757c16ca.c4.e1" ontology_id="CHEBI_16541" text="protein" type="chemical"/>
    <entity charOffset="598-602" id="b950247dbac25ce91de13806e102102a757c16ca.c4.e2" ontology_id="CHEBI_50906" text="role" type="chemical"/>
  </chunk>
  <chunk id="b950247dbac25ce91de13806e102102a757c16ca.c5" text="TGEV infected swine testicular (ST) cells constitute a surrogate system for the search and study of potential anti-coronavirus agents 11, 12, 17 . Herein, we report: (1) tylophorine-based compounds exert potent anti-TGEV replication by directly targeting the viral RNA/ribonucleoprotein (RNP) complex for viral replication/synthesis; (2) NF-κB inhibition also leads to anti-TGEV replication; (3) A combination treatment consisting of both a tylophorine compound and an NF-κB inhibitor acts additively or synergically to more effectively and comprehensively inhibit TGEV replication than either (1) or (2) alone.">
    <entity charOffset="110-133" id="b950247dbac25ce91de13806e102102a757c16ca.c5.e0" ontology_id="CHEBI_149553" text="anti-coronavirus agents" type="chemical"/>
    <entity charOffset="441-452" id="b950247dbac25ce91de13806e102102a757c16ca.c5.e1" ontology_id="CHEBI_9786" text="tylophorine" type="chemical"/>
    <entity charOffset="475-484" id="b950247dbac25ce91de13806e102102a757c16ca.c5.e2" ontology_id="CHEBI_35222" text="inhibitor" type="chemical"/>
  </chunk>
</document>
